Competitive nuclear export of cyclin D1 and Hic-5 regulates anchorage dependence of cell growth and survival

Molecular Biology of the Cell

Volumn 20, Issue 1, 2009, Pages 218-232

  Mori, Kazunori ^a   Hirao, Etsuko ^a   Toya, Yosuke ^a   Oshima, Yukiko ^a   Ishikawa, Fumihiro ^a   Nose, Kiyoshi ^a   Shibanuma, Motoko ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CELL PROTEIN; CYCLIN D1; HIC 5 PROTEIN; MUTANT PROTEIN; PARTICULARLY INTERESTING NEW CYSTEINE HISTIDINE PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; LIMS1 PROTEIN, MOUSE; MULTIPROTEIN COMPLEX; RAS PROTEIN; TGFB1I1 PROTEIN, MOUSE;

ANCHORAGE DEPENDENT GROWTH; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; NUCLEAR EXPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; ACTIVE TRANSPORT; ANIMAL; CELL ADHESION; CELL LINE; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; RNA INTERFERENCE; TWO HYBRID SYSTEM;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL ADHESION; CELL LINE; CELL SURVIVAL; CYCLIN D1; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; HUMANS; MICE; MULTIPROTEIN COMPLEXES; OXIDATION-REDUCTION; RAS PROTEINS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 63049084296     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-04-0428     Document Type: Article

References (53)

1. Alt, J. R., Cleveland, J. L., Hannink, M., and Diehl, J. A. (2000). Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1depenent cellular transformation. Genes Dev. 14, 3102-3114.
2. Alt, J. R., Gladden, A. B., and Diehl, J. A. (2002). p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277, 8517-8523.
3. Assoian, R. K. (1997). Anchorage-dependent cell cycle progression. J. Cell Biol. 136,1-4.
4. Benzeno, S., and Diehl, J. A. (2004). C-terminal sequences direct cyclin D1-CRM1 binding. J. Biol. Chem. 279, 56061-56066.
5. Chiarugi, P., and Fiaschi, T. (2007). Redox signalling in anchorage-dependent cell growth. Cell Signal. 19, 672-682.
6. Chiarugi, P., Pani, G., Giannoni, E., Taddei, L., Colavitti, R., Raugei, G., Symons, M., Borrello, S., Galeotti, T., and Ramponi, G. (2003). Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 161, 933-944.
7. Coqueret, O. (2002). Linking cyclins to transcriptional control. Gene 299, 35-55.
8. de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S., and van Kuilenburg, A. B. (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749.
9. Diehl, J. A. (2002). Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1,226-231.
10. Diehl, J. A., Cheng, M., Roussel, M. F., and Sherr, C. J. (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511.
11. Diehl, J. A., Zindy, F., and Sherr, C. J. (1997). Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11, 957-972.
12. Ewen, M. E., and Lamb, J. (2004). The activities of cyclin D1 that drive tumorigenesis. Trends Mol. Med. 10, 158-162.
13. Fang, F., Orend, G., Watanabe, N., Hunter, T., and Ruoslahti, E. (1996). Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271, 499-502.
14. Finkel, T. (2003). Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254.
15. Freedman, V. H., and Shin, S. I. (1974). Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3, 355-359.
16. Frisch, S. M., and Screaton, R. A. (2001). Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562.
17. Fu, M., Wang, C., Li, Z., Sakamaki, T., and Pestell, R. G. (2004). Minireview: Cyclin D1, normal and abnormal functions. Endocrinology 145, 5439-5447.
18. Gladden, A. B., and Diehl, J. A. (2005). Location, location, location: the role ofcyclin D1 nuclear localization in cancer. J. Cell. Biochem. 96, 906-913.
19. Gotoh, I., Uekita, T., and Seiki, M. (2007). Regulated nucleo-cytoplasmic shuttling of human aci-reductone dioxygenase (hADI1) and its potential role in mRNA processing. Genes Cells 12, 105-117.
20. Guerrero-Santoro, J., Yang, L., Stallcup, M. R., and DeFranco, D. B. (2004). Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation. J. Cell. Biochem. 92, 810-819.
21. Henderson, B. R., and Eleftheriou, A. (2000). A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. Exp. Cell Res. 256, 213-224.
22. Holley, S. L., Heighway, J., and Hoban, P. R. (2005). Induced expression of human CCND1 alternative transcripts in mouse Cyl-1 knockout fibroblasts highlights functional differences. Int. J. Cancer 114, 364-370.
23. Kanome, T., Itoh, N., Ishikawa, F., Mori, K., Kim-Kaneyama, J. R., Nose, K., and Shibanuma, M. (2007). Characterization of Jumping translocation breakpoint (JTB) gene product isolated as a TGF-beta1-inducible clone involved in regulation of mitochondrial function, cell growth and cell death. Oncogene 26, 5991-6001.
24. Kozar, K. et al. (2004). Mouse development and cell proliferation in the absence of D-cyclins. Cell 118, 477-491.
25. Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., and Ewen, M. E. (2003). A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323-334.
26. Lander, H. M. (1997). An essential role for free radicals and derived species in signal transduction. FASEB J. 11, 118-124.
27. Li, J. M., Datto, M. B., Shen, X., Hu, P. P., Yu, Y., and Wang, X. F. (1998). Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites. Nucleic Acids Res. 26, 2449-2456.
28. Li, Y. J., Song, R., Korkola, J. E., Archer, M. C., and Ben-David, Y. (2003). Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis. Oncogene 22, 3452-3462.
29. Lin, X., Nelson, P., and Gelman, I. H. (2000). SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)→S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol. Cell. Biol. 20, 7259-7272.
30. Matsuya, M., Sasaki, H., Aoto, H., Mitaka, T., Nagura, K., Ohba, T., Ishino, M., Takahashi, S., Suzuki, R., and Sasaki, T. (1998). Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions. J. Biol. Chem. 273, 1003-1014.
31. Mori, K., Asakawa, M., Hayashi, M., Imura, M., Ohki, T., Hirao, E., Kim-Kaneyama, J. R., Nose, K., and Shibanuma, M. (2006). Oligomerizing potential of a focal adhesion LIM protein Hic-5 organizing a nuclear-cytoplasmic shuttling complex. J. Biol. Chem. 281, 22048-22061.
32. Nishiya, N., Tachibana, K., Shibanuma, M., Mashimo, J. I., and Nose, K. (2001). Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase. Mol. Cell. Biol. 21, 5332-5345.
33. Nose, K. (2000). Role of reactive oxygen species in the regulation of physiological functions. Biol. Pharm. Bull. 23, 897-903.
34. Oyama, T., Kashiwabara, K., Yoshimoto, K., Arnold, A., and Koerner, F. (1998). Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res. 58, 2876-2880.
35. Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., and Sherr, C. J. (1993). Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7, 1559-1571.
36. Reddig, P. J., and Juliano, R. L. (2005). Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 24, 425-439.
37. Resnitzky, D. (1997). Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression. Mol. Cell. Biol. 17, 5640-5647.
38. Resnitzky, D., Gossen, M., Bujard, H., and Reed, S. I. (1994). Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14, 1669-1679.
39. Rieber, M., and Rieber, M. S. (2006). Cyclin D1 overexpression induces epidermal growth factor-independent resistance to apoptosis linked to BCL-2 in human A431 carcinoma. Apoptosis 11, 121-129.
40. Schulze, A., Zerfass-Thome, K., Berges, J., Middendorp, S., Jansen-Durr, P., and Henglein, B. (1996). Anchorage-dependent transcription of the cyclin A gene. Mol. Cell. Biol. 16, 4632-4638.
41. Schwartz, M. A., and Assoian, R. K. (2001). Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J. Cell Sci. 114, 2553-2560.
42. Sherr, C. J., and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
43. Sherr, C. J., and Roberts, J. M. (2004). Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18, 2699-2711.
44. Shibanuma, M., Kim-Kaneyama, J. R., Ishino, K., Sakamoto, N., Hishiki, T., Yamaguchi, K., Mori, K., Mashimo, J., and Nose, K. (2003). Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol. Biol. Cell 14, 1158-1171.
45. Shibanuma, M., Kim-Kaneyama, J. R., Sato, S., and Nose, K. (2004). A LIM protein, Hic-5, functions as a potential coactivator for Sp1. J. Cell. Biochem. 91, 633-645.
46. Shibanuma, M., Mori, K., Kim-Kaneyama, J. R., and Nose, K. (2005). Involvement of FAK and PTP-PEST in the regulation of redox-sensitive nuclear-cytoplasmic shuttling of a LIM protein, Hic-5. Antioxid. Redox Signal. 7, 335-347.
47. Thannickal, V. J., and Fanburg, B. L. (2000). Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L1005-L1028. Thomas, S. M., Hagel, M., and Turner, C. E. (1999). Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. J. Cell Sci. 112(Pt 2), 181-190.
48. Wang, L. H. (2004). Molecular signaling regulating anchorage-independent growth of cancer cells. Mt. Sinai J. Med. 71, 361-367.
49. Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S. (1995). Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med. 1, 1257-1260.
50. Yang, J. J., Kang, J. S., and Krauss, R. S. (1998). Ras signals to the cell cycle machinery via multiple pathways to induce anchorage-independent growth. Mol. Cell. Biol. 18, 2586-2595.
51. Yang, L., Guerrero, J., Hong, H., DeFranco, D. B., and Stallcup, M. R. (2000). Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 11, 2007-2018.
52. Yu, Q., Geng, Y., and Sicinski, P. (2001). Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017-1021.
53. Zhu, X., Ohtsubo, M., Bohmer, R. M., Roberts, J. M., and Assoian, R. K. (1996). Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133, 391-403.